DEVELOPMENT OF A REGULATORY POST-MARKETING STUDIES DATABASE

被引:0
|
作者
Caron, M. [1 ]
Mouchet, J. [1 ]
Emery, M. P.
Longin, J. [1 ,2 ]
Maier, W. C. [3 ]
机构
[1] MAPI Res Trust, Lyon, France
[2] MAPI, Lyon, France
[3] MAPI EPI, Lyon, France
关键词
D O I
10.1016/S1098-3015(10)73180-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A24 / A24
页数:1
相关论文
共 50 条
  • [31] Post-marketing studies - The work of the Drug Safety Research Unit
    Mackay, FJ
    DRUG SAFETY, 1998, 19 (05) : 343 - 353
  • [32] PREDICTION OF POST-MARKETING SAFETY FROM CLINICAL-STUDIES
    EAST, MO
    RISK AND CONSENT TO RISK IN MEDICINE, 1989, : 39 - 52
  • [33] POST-MARKETING SURVEILLANCE OF DRUGS
    LAWSON, DH
    BRITISH MEDICAL JOURNAL, 1979, 2 (6189): : 546 - 546
  • [34] Efficacy and safety of nateglinide in post-marketing surveillance studies in Japan
    Damholt, BB
    Golor, G
    Wierich, W
    Pedersen, PC
    Ekblom, M
    Zdravkovic, M
    DIABETES, 2005, 54 : A114 - A114
  • [35] Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies
    Khan, Zakir
    Karatas, Yusuf
    Akici, Ahmet
    Martins, Maria Auxiliadora Parreiras
    Ahmad, Nafees
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [36] POST-MARKETING SAFETY STUDIES Authors' reply to Fralick and Kesselheim
    Spelsberg, Angela
    Keil, Ulrich
    Prugger, Christof
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [37] Post-marketing surveillance of buprenorphine
    Ray, R
    Pal, H
    Kumar, R
    Maulick, P
    Mangla, R
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (09) : 615 - 619
  • [38] PROBLEMS OF POST-MARKETING SURVEILLANCE
    CASTLE, WM
    NICHOLLS, JT
    DOWNIE, CC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) : 581 - 585
  • [39] Post-marketing safety evaluation of lurbinectedin: a pharmacovigilance analysis based on the FAERS database
    Li, Zhao
    Guo, Changying
    Liu, Xingfei
    Qiu, Zhengzhou
    Zhang, Ruilin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [40] Post-marketing safety monitoring of tirzepatide: a pharmacovigilance study based on the FAERS database
    Chen, Han
    Ding, Yuhang
    Shan, Yongqi
    EXPERT OPINION ON DRUG SAFETY, 2025,